Want to see JP:4350 full AI Analyst Report?
4350 Stock Chart & Stats
¥521.00
-¥6.00(-1.44%)
At close: 4:00 PM EST
¥521.00
-¥6.00(-1.44%)
Day’s Range― - ―
52-Week Range¥433.00 - ¥558.00
Previous CloseN/A
Volume13.10K
Average Volume (3M)110.75K
Market Cap
¥14.46B
Enterprise Value¥37.19K
Total Cash (Recent Filing)¥7.28B
Total Debt (Recent Filing)¥30.51B
Price to Earnings (P/E)16.4
Beta0.35
Next Earnings
Nov 06, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield2.46%
Share Statistics
EPS (TTM)29.70
Shares Outstanding30,642,600
10 Day Avg. Volume66,330
30 Day Avg. Volume110,753
Financial Highlights & Ratios
PEG Ratio-0.97
Price to Book (P/B)0.91
Price to Sales (P/S)0.12
P/FCF Ratio-2.66
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)99.2
Revenue Forecast (FY)¥134.00B
Bulls Say, Bears Say
Bulls Say
Resilient Revenue GrowthSustained revenue expansion indicates resilient demand for the company’s healthcare and pharmaceutical support services. Continued top-line growth provides a foundation for operating leverage if management can control costs and improve profitability.
Improving Balance-Sheet TrajectoryDebt reduction alongside rising equity suggests gradual strengthening of the capital base. Although leverage remains high, this direction can improve financial flexibility over time and reduce balance-sheet pressure if the trend continues.
Healthy Gross Profit BaseA healthy gross-profit base indicates that the underlying services retain economic value and may support future earnings recovery. Restoring cost discipline or improving operating efficiency could convert this gross-profit strength into better margins.
Bears Say
Declining ProfitabilityRepeated net-income declines and sharply negative EPS growth indicate weakening earnings quality despite revenue expansion. Persistent cost increases or other operating pressures could limit reinvestment capacity and reduce the benefit of future sales growth.
Negative Operating Cash FlowThe reversal to negative operating and free cash flow is a material concern because it weakens internally funded growth and may reflect working-capital strain or heavier cash needs. Sustained cash burn would increase dependence on financing.
Elevated LeverageA debt-heavy capital structure reduces financial flexibility while earnings and cash generation are under pressure. High leverage can constrain investment, raise refinancing sensitivity, and make a prolonged profitability downturn more difficult to absorb.
Medical System Network Co., Ltd. News
4350 FAQ
What was Medical System Network Co., Ltd.’s price range in the past 12 months?
Medical System Network Co., Ltd. lowest stock price was ¥433.00 and its highest was ¥558.00 in the past 12 months.
What is Medical System Network Co., Ltd.’s market cap?
Medical System Network Co., Ltd.’s market cap is ¥14.46B.
When is Medical System Network Co., Ltd.’s upcoming earnings report date?
Medical System Network Co., Ltd.’s upcoming earnings report date is Nov 06, 2026 which is in 55 days.
How were Medical System Network Co., Ltd.’s earnings last quarter?
Medical System Network Co., Ltd. released its earnings results on Aug 07, 2026. The company reported -¥4.27 earnings per share for the quarter.
Is Medical System Network Co., Ltd. overvalued?
According to Wall Street analysts Medical System Network Co., Ltd.’s price is currently Overvalued.
Does Medical System Network Co., Ltd. pay dividends?
Medical System Network Co., Ltd. pays a Semiannually dividend of ¥6 which represents an annual dividend yield of 2.46%. See more information on Medical System Network Co., Ltd. dividends here
What is Medical System Network Co., Ltd.’s EPS estimate?
Medical System Network Co., Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Medical System Network Co., Ltd. have?
Medical System Network Co., Ltd. has 30,642,600 shares outstanding.
What happened to Medical System Network Co., Ltd.’s price movement after its last earnings report?
Medical System Network Co., Ltd. reported an EPS of -¥4.27 in its last earnings report. Following the earnings report the stock price went up 0.825%.
Which hedge fund is a major shareholder of Medical System Network Co., Ltd.?
Currently, no hedge funds are holding shares in JP:4350
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Medical System Network Co., Ltd.
Headquartered in Sapporo, Japan, and established in 1999, Medical System Network Co., Ltd. functions as a comprehensive provider within the healthcare industry. Its core business involves the distribution of pharmaceutical products to a diverse range of clients, including pharmacies, hospitals, clinics, and drug wholesalers. The company's operations are divided into several key segments. The Community Pharmacy Network division primarily facilitates the procurement and sale of pharmaceuticals among pharmacies, hospitals, clinics, and wholesale distributors. This segment also delivers crucial inventory management and liquidation services, manufactures and markets its own pharmaceutical offerings, and handles price negotiations with suppliers. Furthermore, it maintains a specialized platform designed to assist with pharmacy transitions. Within the Leasing and Facility-related segment, Medical System Network provides building rental services, develops optimal locations for new pharmacies, and offers consulting expertise to medical practitioners. The Meal Catering segment is responsible for delivering food services to hospitals and various welfare facilities. Beyond these primary areas, the company also offers nursing care and specialized advisory counseling services tailored for the medical treatment sector.
Technical Analysis
Sundrug Co
―
Sugi Holdings Co
―
TSURUHA Holdings
―
COSMOS Pharmaceutical Corporation
―
KUSURI NO AOKI HOLDINGS CO.,LTD.
―